See also this year's filing and all EDGAR filings for this company.
PDF Report 0001595097_2022_Corbus_Pharmaceuticals_Holdings_Inc.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001595097, Corbus Pharmaceuticals Holdings Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 100,204,637 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,392,696 |
| 3 | remainder_Assets | 5,132,920 |
| 4 | LiabilitiesCurrent | 17,007,529 |
| 5 | LiabilitiesNoncurrent | 21,614,697 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 20,425,444 |
| 9 | ResearchAndDevelopmentExpense | 36,445,285 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 881,705 |
| 12 | remainder_NetIncome | 10,348,598 |
| 13 | remainder_ComprehensiveNetIncome | -62,445 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 107,730,253 |
| 1 | Liabilities | 38,622,226 |
| 2 | Expenses | 56,870,729 |
| 3 | Revenues | 881,705 |
| 4 | StockholdersEquity | 69,108,027 |
| 5 | NetIncome | -45,640,426 |
| 6 | ComprehensiveNetIncome | -45,671,648 |
| 7 | BaseVar | 107,257,978 |
| 8 | EconomicCapitalRatio | 1.00 |
Edgar->Model Mapping
Feature Distribution
Change over Time
